Skip to main content
CVS logo

CVS Health Corporation

CVSNYSEHealthcareHealthcare Plans

$93.47Today:- (-)1Y +16.54%

As of Oct 23, 2026 close

Market cap
$120.30B
P/E (TTM)
24.60
Forward P/E
22.88
Dividend yield
3.52%
52-week range
$69.51$110.68
Volume (live)
-
Avg. volume (3M)
9.00M

CVS Health Corporation (CVS) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for CVS Health Corporation stock.

Analyst Consensus Rating

Investment consensus from 23 professional research analysts

Consensus Rating

Buy
Based on 23 unique analysts
(34 total ratings in last 90 days)
Very High Confidence∞:1 Buy/Sell

Average Price Target

$114.59
+22.60% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CVS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Allen Lutz
BofA Securities
BuyMaintains
$110.00
Michael Cherny
Leerink Partners
BuyReiterates
$119.00 → $112.00
Charles Rhyee
TD Cowen
BuyMaintains
$110.00
Moumi Mondal
Zacks Equity Research
HoldInitiates Coverage
-
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Ben Hendrix
RBC Capital
BuyMaintains
$113.00
Allen Lutz
BofA Securities
BuyMaintains
$110.00
Lance Wilkes
Bernstein
BuyMaintains
$106.00 → $112.00
Elizabeth Anderson CFA
Evercore ISI Group
BuyMaintains
$125.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Sridatri Sarkar
Zacks Equity Research
HoldInitiates Coverage
-
Allen Lutz
BofA Securities
BuyMaintains
$1050.00 → $120.00
Stephen Baxter
Wells Fargo
BuyMaintains
$123.00
Sridatri Sarkar
Zacks Equity Research
HoldInitiates Coverage
-
Kevin Caliendo
UBS
BuyReiterates
$126.00 → $118.00
Moumi Mondal
Zacks Equity Research
HoldInitiates Coverage
-
Brian Tanquilut
Jefferies
BuyMaintains
$120.00
Jessica Tassan
Piper Sandler
BuyMaintains
$113.00
Charles Rhyee
TD Cowen
BuyMaintains
$110.00
Steven Silver
Argus Research
BuyMaintains
$104.00 → $114.00
Lisa Gill
JP Morgan
BuyMaintains
$111.00 → $118.00
Piyali Saha Sikdar
Zacks Equity Research
BuyInitiates Coverage
-
Erin Wright
Morgan Stanley
BuyInitiates Coverage
$111.00
David S Macdonald
Truist
BuyReiterates
$118.00
Andrew Mok CFA
Barclays
BuyMaintains
$106.00 → $108.00
Michael Ha
Baird
BuyMaintains
$94.00 → $107.00
Shaun Pruitt
Zacks Equity Research
HoldInitiates Coverage
-
Ben Hendrix
RBC Capital
BuyMaintains
$113.00
Elizabeth Anderson CFA
Evercore ISI Group
BuyMaintains
$130.00 → $125.00
Allen Lutz
BofA Securities
BuyReiterates
$120.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Scott Fidel
Goldman Sachs
BuyMaintains
$104.00 → $116.00
Kaibalya Pravo Dey
Zacks Equity Research
BuyInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 16, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for CVS?

The analyst consensus rating for CVS is Buy, based on the latest ratings from 23 analysts over the last 90 days.

What is the average price target for CVS?

The average 12-month price target for CVS is $114.59, representing an upside of 22.6% from the Oct 23, 2026 close of $93.47.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.